Terms: = Skin cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha
203 results:
1. Dissolving Microneedle-Based Cascade-Activation Nanoplatform for Enhanced Photodynamic Therapy of skin cancer.
Ma J; Tai Z; Li Y; Li Y; Wang J; Zhou T; Shen M; Xin R; Shen C; Zhu Q; Chen Z
Int J Nanomedicine; 2024; 19():2057-2070. PubMed ID: 38482522
[TBL] [Abstract] [Full Text] [Related]
2. Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Weber JS; Carlino MS; Khattak A; Meniawy T; Ansstas G; Taylor MH; Kim KB; McKean M; Long GV; Sullivan RJ; Faries M; Tran TT; Cowey CL; Pecora A; Shaheen M; Segar J; Medina T; Atkinson V; Gibney GT; Luke JJ; Thomas S; Buchbinder EI; Healy JA; Huang M; Morrissey M; Feldman I; Sehgal V; Robert-Tissot C; Hou P; Zhu L; Brown M; Aanur P; Meehan RS; Zaks T
Lancet; 2024 Feb; 403(10427):632-644. PubMed ID: 38246194
[TBL] [Abstract] [Full Text] [Related]
3. EEF1A2 promotes hif1a mediated breast cancer angiogenesis in normoxia and participates in a positive feedback loop with hif1a in hypoxia.
Patel SA; Hassan MK; Naik M; Mohapatra N; Balan P; Korrapati PS; Dixit M
Br J Cancer; 2024 Feb; 130(2):184-200. PubMed ID: 38012382
[TBL] [Abstract] [Full Text] [Related]
4. The effects of ALK5 inhibition and simultaneous inhibition or activation of HIF-1α in melanoma tumor growth and angiogenesis.
Zarin B; Nedaeinia R; Laher I; Manian M; Javanmard SH
Tumour Biol; 2023; 45(1):111-126. PubMed ID: 37927290
[TBL] [Abstract] [Full Text] [Related]
5. Hypoxic microenvironment promotes dermal fibroblast migration and proliferation via a BNIP3-autophagy pathway.
Zhang C; Li H; Jiang M; Zhang Q; Chen J; Jia J; Zhang Z; Yu H; Zhang J; Zhang J
FEBS J; 2024 Jan; 291(2):358-375. PubMed ID: 37873601
[TBL] [Abstract] [Full Text] [Related]
6. IMP3 Immunohistochemical Expression Is Related with Progression and Metastases in Xenografted and Cutaneous Melanomas.
Martin-Morales N; Padial-Molina M; Tovar I; De Araujo Farias V; Hernández-Cortés P; Ramirez-Moreno E; Caba-Molina M; Davis J; Carrero Castaño A; Ruiz de Almodovar JM; Galindo-Moreno P; Oliver-Pozo J; O'Valle Ravassa FJ
Pathobiology; 2024; 91(2):132-143. PubMed ID: 37797584
[TBL] [Abstract] [Full Text] [Related]
7. Functional Involvement of ADRA1D in Cutaneous Melanoma Progression and Angiogenesis.
Wang J; Ning D; Xie D; Chen X; Cao X; Wan C
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):44-50. PubMed ID: 37571902
[TBL] [Abstract] [Full Text] [Related]
8. 3-deazaneplanocin A, a histone methyltransferase inhibitor, improved the chemoresistance induced under hypoxia in melanoma cells.
Hosokawa M; Tetsumoto S; Yasui M; Kono Y; Ogawara KI
Biochem Biophys Res Commun; 2023 Oct; 677():26-30. PubMed ID: 37542772
[TBL] [Abstract] [Full Text] [Related]
9. Metabolic Signature of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Expression of Hypoxia-inducible Factor-1α and Several of Its Downstream Targets.
Toberer F; Winkler JK; Haenssle HA; Heinzel-Gutenbrunner M; Enk A; Hartschuh W; Helmbold P; Kutzner H; Helbig D
Acta Dermatovenerol Croat; 2022 Jul; 30(1):25-31. PubMed ID: 36153716
[TBL] [Abstract] [Full Text] [Related]
10. Hypoxia and Ezrin Expression in Primary Melanoma Have High Prognostic Relevance.
Maccio U; Mihic A; Lenggenhager D; Kolm I; Mittmann C; Heikenwälder M; Lorentzen A; Mihic-Probst D
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142656
[TBL] [Abstract] [Full Text] [Related]
11. Construction and verification of a hypoxia-related nine-gene prognostic model in uveal melanoma based on integrated single-cell and bulk RNA sequencing analyses.
Zhang X; Qiu J; Huang F; Han P; Shan K; Zhang C
Exp Eye Res; 2022 Oct; 223():109214. PubMed ID: 35981602
[TBL] [Abstract] [Full Text] [Related]
12. Association of hypoxia inducible factor 1-Alpha gene polymorphisms with multiple disease risks: A comprehensive meta-analysis.
Harun-Or-Roshid M; Ali MB; Jesmin ; Mollah MNH
PLoS One; 2022; 17(8):e0273042. PubMed ID: 35972942
[TBL] [Abstract] [Full Text] [Related]
13.
Liu J; Lin J; Wang X; Zheng X; Gao X; Huang Y; Chen G; Xiong J; Lan B; Chen C; Si L; Chen Y
Front Immunol; 2022; 13():725679. PubMed ID: 35844619
[TBL] [Abstract] [Full Text] [Related]
14. The Protective Role of pVHL in Imiquimod-Induced Psoriasis-like skin Inflammation.
Martínez-Torres I; Tepale-Segura A; Castro-Escamilla O; Cancino-Diaz JC; Rodríguez-Martínez S; Perez-Tapia SM; Bonifaz LC; Cancino-Diaz ME
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563616
[TBL] [Abstract] [Full Text] [Related]
15. Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy.
Shurin MR; Umansky V
J Clin Invest; 2022 May; 132(9):. PubMed ID: 35499071
[TBL] [Abstract] [Full Text] [Related]
16. TLR4 Agonist and Hypoxia Synergistically Promote the Formation of TLR4/NF-
Zhao B; Niu X; Huang S; Yang J; Wei Y; Wang X; Wang J; Wang Y; Guo X
Anal Cell Pathol (Amst); 2022; 2022():4201262. PubMed ID: 35464826
[TBL] [Abstract] [Full Text] [Related]
17. 2-Methoxyestradiol Inhibits Radiation-Induced skin Injuries.
Kim JH; Nam JK; Kim AR; Park MS; Lee HJ; Park J; Kim J; Lee YJ
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456989
[TBL] [Abstract] [Full Text] [Related]
18. Remotely boosting hyaluronidase activity to normalize the hypoxic immunosuppressive tumor microenvironment for photothermal immunotherapy.
Liu Y; Xu D; Liu Y; Zheng X; Zang J; Ye W; Zhao Y; He R; Ruan S; Zhang T; Dong H; Li Y; Li Y
Biomaterials; 2022 May; 284():121516. PubMed ID: 35436740
[TBL] [Abstract] [Full Text] [Related]
19. Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo.
Niessner H; Burkard M; Leischner C; Renner O; Plöger S; Meraz-Torres F; Böcker M; Hirn C; Lauer UM; Venturelli S; Busch C; Sinnberg T
Cells; 2022 Apr; 11(7):. PubMed ID: 35406796
[TBL] [Abstract] [Full Text] [Related]
20. Single cell transcriptomic landscape of diabetic foot ulcers.
Theocharidis G; Thomas BE; Sarkar D; Mumme HL; Pilcher WJR; Dwivedi B; Sandoval-Schaefer T; Sîrbulescu RF; Kafanas A; Mezghani I; Wang P; Lobao A; Vlachos IS; Dash B; Hsia HC; Horsley V; Bhasin SS; Veves A; Bhasin M
Nat Commun; 2022 Jan; 13(1):181. PubMed ID: 35013299
[TBL] [Abstract] [Full Text] [Related]
[Next]